LXRX · Lexicon Pharmaceuticals Inc. Common Stock
View on chartInsiders & Stakes
| Participations S.a r.l. Artal | ▲ Buy | Option Exercise | 175,156,062 Shares held | 4/30/2026 | View profile |
| Artal International S.C.A. Director | ▲ Buy | Option Exercise | 136,180,481 Shares held | 5/10/2024 | View profile |
| Invus US Partners LLC Director | ▲ Buy | Open Market | 5,451,204 Shares held | 8/5/2022 | View profile |
| DEBBANE RAYMOND Director | ▲ Buy | Option Exercise | 1,995,498 Shares held | 6/3/2026 | View profile |
| COATS LONNEL Chief Executive Officer | ▼ Sell | Tax Withholding | 1,098,068 Shares held | 2/28/2024 | View profile |
| Crum Brian T SVP, General Counsel & Secr. | ▼ Sell | Tax Withholding | 428,802 Shares held | 2/28/2026 | View profile |
| Philippe Amouyal Director | ▲ Buy | Option Exercise | 374,486 Shares held | 6/3/2026 | View profile |
| Invus Global Management, LLC | ▲ Buy | Grant | 367,145 Shares held | 2/2/2026 | View profile |
| MAIN ALAN J EVP, Innov & Chem Sciences | ▼ Sell | Tax Withholding | 339,104 Shares held | 2/28/2025 | View profile |
| WADE JEFFREY L President and CFO | ▼ Sell | Tax Withholding | 324,214 Shares held | 2/28/2024 | View profile |
| Granowitz Craig B SVP, Chief Medical Officer | ▼ Sell | Tax Withholding | 323,430 Shares held | 2/28/2026 | View profile |
| Exton Michael Chief Executive Officer | ▼ Sell | Tax Withholding | 298,432 Shares held | 2/28/2026 | View profile |
| SOBECKI CHRISTOPHER J Director | ▲ Buy | Option Exercise | 293,177 Shares held | 6/3/2026 | View profile |
| McDermott Wendy VP, Human Resources | ▼ Sell | Tax Withholding | 277,945 Shares held | 2/28/2026 | View profile |
| Sam L. Barker Director | ▲ Buy | Option Exercise | 213,771 Shares held | 6/3/2026 | View profile |
| Swain Judith L Director | ▲ Buy | Option Exercise | 174,486 Shares held | 6/3/2026 | View profile |
| Kassler-Taub Kenneth B. SVP, Regulatory & QA | ▼ Sell | Tax Withholding | 162,672 Shares held | 2/28/2024 | View profile |
| Gopinathan Suma SVP, Discovery | ▼ Sell | Tax Withholding | 150,132 Shares held | 2/28/2026 | View profile |
| Diane E. Sullivan Director | ▲ Buy | Option Exercise | 126,122 Shares held | 6/3/2026 | View profile |
| Coiante Scott M SVP, Chief Financial Officer | ▼ Sell | Tax Withholding | 105,356 Shares held | 2/28/2026 | View profile |
| DeFrancesco Lisa SVP, IR and Corp Comm | ▼ Sell | Tax Withholding | 93,869 Shares held | 2/28/2026 | View profile |
| Cheung Ivan Director | ▲ Buy | Option Exercise | 89,312 Shares held | 6/3/2026 | View profile |
| Alexander Kristen VP, Finance and Accounting | ▼ Sell | Tax Withholding | 76,368 Shares held | 2/28/2025 | View profile |
| Seth Kiernan VP, Chief Commercial Officer | ▼ Sell | Tax Withholding | 53,136 Shares held | 2/28/2023 | View profile |
| LEFKOWITZ ROBERT J MD Director | ▲ Buy | Option Exercise | 48,364 Shares held | 4/28/2024 | View profile |
| NIES ALAN S Director | ▲ Buy | Option Exercise | 41,046 Shares held | 5/21/2023 | View profile |
| Palantoni Frank Director | ▲ Buy | Option Exercise | 40,332 Shares held | 5/21/2023 | View profile |
| Martens Rachel Yap SVP, Partnerships & Corp Strat | ▼ Sell | Tax Withholding | 31,264 Shares held | 2/28/2026 | View profile |
Transaction History
| Swain Judith L | ▲ Buy | Option Exercise | 89,312 | $0 | 6/3/2026 |
| Diane E. Sullivan | ▲ Buy | Option Exercise | 89,312 | $0 | 6/3/2026 |
| SOBECKI CHRISTOPHER J | ▲ Buy | Option Exercise | 89,312 | $0 | 6/3/2026 |
| Cheung Ivan | ▲ Buy | Option Exercise | 89,312 | $0 | 6/3/2026 |
| Sam L. Barker | ▲ Buy | Option Exercise | 89,312 | $0 | 6/3/2026 |
| DEBBANE RAYMOND | ▲ Buy | Option Exercise | 89,312 | $0 | 6/3/2026 |
| Philippe Amouyal | ▲ Buy | Option Exercise | 89,312 | $0 | 6/3/2026 |
| Participations S.a r.l. Artal | ▲ Buy | Option Exercise | 20,421,735 | $0 | 4/30/2026 |
| McDermott Wendy | ▼ Sell | Tax Withholding | 68,107 | $100K | 2/28/2026 |
| Martens Rachel Yap | ▼ Sell | Tax Withholding | 35,826 | $53K | 2/28/2026 |
| McDermott Wendy | ▲ Buy | Option Exercise | 144,393 | — | 2/28/2026 |
| McDermott Wendy | ▲ Buy | Option Exercise | 52,316 | — | 2/28/2026 |
| Granowitz Craig B | ▲ Buy | Option Exercise | 35,790 | — | 2/28/2026 |
| Martens Rachel Yap | ▲ Buy | Option Exercise | 67,090 | — | 2/28/2026 |
| McDermott Wendy | ▲ Buy | Option Exercise | 27,697 | — | 2/28/2026 |
| Granowitz Craig B | ▲ Buy | Option Exercise | 74,226 | — | 2/28/2026 |
| Granowitz Craig B | ▲ Buy | Option Exercise | 202,260 | — | 2/28/2026 |
| Granowitz Craig B | ▼ Sell | Tax Withholding | 109,098 | $160K | 2/28/2026 |
| Gopinathan Suma | ▲ Buy | Option Exercise | 14,000 | — | 2/28/2026 |
| Gopinathan Suma | ▲ Buy | Option Exercise | 20,310 | — | 2/28/2026 |
| Gopinathan Suma | ▲ Buy | Option Exercise | 65,640 | — | 2/28/2026 |
| Gopinathan Suma | ▼ Sell | Tax Withholding | 24,338 | $36K | 2/28/2026 |
| DeFrancesco Lisa | ▲ Buy | Option Exercise | 24,674 | — | 2/28/2026 |
| DeFrancesco Lisa | ▲ Buy | Option Exercise | 128,190 | — | 2/28/2026 |
| DeFrancesco Lisa | ▼ Sell | Tax Withholding | 74,572 | $110K | 2/28/2026 |
| Crum Brian T | ▲ Buy | Option Exercise | 33,457 | — | 2/28/2026 |
| Crum Brian T | ▲ Buy | Option Exercise | 69,386 | — | 2/28/2026 |
| Crum Brian T | ▲ Buy | Option Exercise | 170,163 | — | 2/28/2026 |
| Crum Brian T | ▼ Sell | Tax Withholding | 105,019 | $154K | 2/28/2026 |
| Coiante Scott M | ▲ Buy | Option Exercise | 160,237 | — | 2/28/2026 |
| Coiante Scott M | ▼ Sell | Tax Withholding | 54,881 | $81K | 2/28/2026 |
| Exton Michael | ▲ Buy | Option Exercise | 503,263 | — | 2/28/2026 |
| Exton Michael | ▼ Sell | Tax Withholding | 204,831 | $301K | 2/28/2026 |
| DEBBANE RAYMOND | ▲ Buy | Open Market | 2,000 | $3K | 2/25/2026 |
| DEBBANE RAYMOND | ▲ Buy | Open Market | 100,000 | $147K | 2/23/2026 |
| DEBBANE RAYMOND | ▲ Buy | Open Market | 100,000 | $148K | 2/20/2026 |
| DEBBANE RAYMOND | ▲ Buy | Open Market | 50,000 | $72K | 2/19/2026 |
| DEBBANE RAYMOND | ▲ Buy | Open Market | 133,688 | $176K | 2/18/2026 |
| DEBBANE RAYMOND | ▲ Buy | Open Market | 76,857 | $101K | 2/17/2026 |
| Participations S.a r.l. Artal | ▲ Buy | Grant | 41,290 | $2.7M | 2/17/2026 |
| DEBBANE RAYMOND | ▲ Buy | Open Market | 57,952 | $76K | 2/13/2026 |
| Invus Global Management, LLC | ▲ Buy | Open Market | 1,538,462 | $2.0M | 2/2/2026 |
| Invus Global Management, LLC | ▲ Buy | Grant | 367,145 | $23.9M | 2/2/2026 |
| Invus Global Management, LLC | ▲ Buy | Grant | 18,553,846 | $24.1M | 2/2/2026 |
| Invus Global Management, LLC | ▲ Buy | Grant | 3,846,154 | $5.0M | 2/2/2026 |
| Swain Judith L | ▲ Buy | Option Exercise | 36,810 | $0 | 5/13/2025 |
| Diane E. Sullivan | ▲ Buy | Option Exercise | 36,810 | $0 | 5/13/2025 |
| SOBECKI CHRISTOPHER J | ▲ Buy | Option Exercise | 36,810 | $0 | 5/13/2025 |
| Sam L. Barker | ▲ Buy | Option Exercise | 36,810 | $0 | 5/13/2025 |
| Philippe Amouyal | ▲ Buy | Option Exercise | 36,810 | $0 | 5/13/2025 |
| DEBBANE RAYMOND | ▲ Buy | Option Exercise | 36,810 | $0 | 5/13/2025 |
| DeFrancesco Lisa | ▼ Sell | Tax Withholding | 9,096 | $6K | 2/28/2025 |
| Crum Brian T | ▲ Buy | Option Exercise | 33,456 | — | 2/28/2025 |
| Crum Brian T | ▲ Buy | Option Exercise | 69,387 | — | 2/28/2025 |
| Crum Brian T | ▼ Sell | Tax Withholding | 45,622 | $31K | 2/28/2025 |
| Crum Brian T | ▲ Buy | Option Exercise | 26,097 | — | 2/28/2025 |
| Alexander Kristen | ▲ Buy | Option Exercise | 10,617 | — | 2/28/2025 |
| Alexander Kristen | ▲ Buy | Option Exercise | 15,926 | — | 2/28/2025 |
| Alexander Kristen | ▲ Buy | Option Exercise | 19,887 | — | 2/28/2025 |
| Alexander Kristen | ▼ Sell | Tax Withholding | 17,862 | $12K | 2/28/2025 |
| McDermott Wendy | ▲ Buy | Option Exercise | 18,943 | — | 2/28/2025 |
| McDermott Wendy | ▲ Buy | Option Exercise | 27,696 | — | 2/28/2025 |
| McDermott Wendy | ▲ Buy | Option Exercise | 52,317 | — | 2/28/2025 |
| McDermott Wendy | ▼ Sell | Tax Withholding | 30,004 | $20K | 2/28/2025 |
| MAIN ALAN J | ▲ Buy | Option Exercise | 25,667 | — | 2/28/2025 |
| MAIN ALAN J | ▲ Buy | Option Exercise | 32,904 | — | 2/28/2025 |
| MAIN ALAN J | ▲ Buy | Option Exercise | 68,243 | — | 2/28/2025 |
| MAIN ALAN J | ▼ Sell | Tax Withholding | 43,434 | $29K | 2/28/2025 |
| Granowitz Craig B | ▲ Buy | Option Exercise | 27,917 | — | 2/28/2025 |
| Granowitz Craig B | ▲ Buy | Option Exercise | 35,790 | — | 2/28/2025 |
| Granowitz Craig B | ▲ Buy | Option Exercise | 74,227 | — | 2/28/2025 |
| Granowitz Craig B | ▼ Sell | Tax Withholding | 65,308 | $44K | 2/28/2025 |
| DeFrancesco Lisa | ▲ Buy | Option Exercise | 24,673 | — | 2/28/2025 |
| Artal International S.C.A. | ▲ Buy | Option Exercise | 57,546,100 | — | 5/10/2024 |
| Swain Judith L | ▲ Buy | Option Exercise | 8,032 | $0 | 4/28/2024 |
| SOBECKI CHRISTOPHER J | ▲ Buy | Option Exercise | 8,032 | $0 | 4/28/2024 |
| LEFKOWITZ ROBERT J MD | ▲ Buy | Option Exercise | 8,032 | $0 | 4/28/2024 |
| DEBBANE RAYMOND | ▲ Buy | Option Exercise | 8,032 | $0 | 4/28/2024 |
| Sam L. Barker | ▲ Buy | Option Exercise | 8,032 | $0 | 4/28/2024 |
| Philippe Amouyal | ▲ Buy | Option Exercise | 8,032 | $0 | 4/28/2024 |
| Artal International S.C.A. | ▲ Buy | Grant | 1,150,922 | $124.9M | 3/13/2024 |
| McDermott Wendy | ▼ Sell | Tax Withholding | 22,425 | $59K | 2/28/2024 |
| MAIN ALAN J | ▲ Buy | Option Exercise | 32,903 | — | 2/28/2024 |
| MAIN ALAN J | ▼ Sell | Tax Withholding | 24,408 | $64K | 2/28/2024 |
| COATS LONNEL | ▲ Buy | Option Exercise | 33,333 | — | 2/28/2024 |
| COATS LONNEL | ▲ Buy | Option Exercise | 91,364 | — | 2/28/2024 |
| COATS LONNEL | ▲ Buy | Option Exercise | 120,383 | — | 2/28/2024 |
| COATS LONNEL | ▼ Sell | Tax Withholding | 61,371 | $161K | 2/28/2024 |
| MAIN ALAN J | ▲ Buy | Option Exercise | 25,666 | — | 2/28/2024 |
| Kassler-Taub Kenneth B. | ▲ Buy | Option Exercise | 7,087 | — | 2/28/2024 |
| MAIN ALAN J | ▲ Buy | Option Exercise | 8,977 | — | 2/28/2024 |
| Kassler-Taub Kenneth B. | ▲ Buy | Option Exercise | 27,556 | — | 2/28/2024 |
| Kassler-Taub Kenneth B. | ▲ Buy | Option Exercise | 32,757 | — | 2/28/2024 |
| Kassler-Taub Kenneth B. | ▼ Sell | Tax Withholding | 24,353 | $64K | 2/28/2024 |
| Granowitz Craig B | ▲ Buy | Option Exercise | 27,916 | — | 2/28/2024 |
| Granowitz Craig B | ▲ Buy | Option Exercise | 35,790 | — | 2/28/2024 |
| Granowitz Craig B | ▼ Sell | Tax Withholding | 31,265 | $82K | 2/28/2024 |
| Crum Brian T | ▲ Buy | Option Exercise | 8,750 | — | 2/28/2024 |
| Crum Brian T | ▲ Buy | Option Exercise | 26,096 | — | 2/28/2024 |
| Crum Brian T | ▲ Buy | Option Exercise | 33,457 | — | 2/28/2024 |
| Crum Brian T | ▼ Sell | Tax Withholding | 25,604 | $67K | 2/28/2024 |
| Alexander Kristen | ▲ Buy | Option Exercise | 2,700 | — | 2/28/2024 |
| Alexander Kristen | ▲ Buy | Option Exercise | 10,616 | — | 2/28/2024 |
| Alexander Kristen | ▲ Buy | Option Exercise | 15,927 | — | 2/28/2024 |
| Alexander Kristen | ▼ Sell | Tax Withholding | 11,793 | $31K | 2/28/2024 |
| WADE JEFFREY L | ▲ Buy | Option Exercise | 11,177 | — | 2/28/2024 |
| WADE JEFFREY L | ▲ Buy | Option Exercise | 37,274 | — | 2/28/2024 |
| WADE JEFFREY L | ▲ Buy | Option Exercise | 49,113 | — | 2/28/2024 |
| WADE JEFFREY L | ▼ Sell | Tax Withholding | 37,691 | $99K | 2/28/2024 |
| McDermott Wendy | ▲ Buy | Option Exercise | 18,944 | — | 2/28/2024 |
| McDermott Wendy | ▲ Buy | Option Exercise | 27,697 | — | 2/28/2024 |
| COATS LONNEL | ▲ Buy | Open Market | 90,000 | $95K | 11/16/2023 |
| Philippe Amouyal | ▲ Buy | Open Market | 200,000 | $202K | 11/13/2023 |
| COATS LONNEL | ▲ Buy | Open Market | 10,000 | $10K | 11/10/2023 |
| DEBBANE RAYMOND | ▲ Buy | Open Market | 148,820 | $154K | 10/12/2023 |
| DEBBANE RAYMOND | ▲ Buy | Open Market | 342,874 | $371K | 10/11/2023 |
| DEBBANE RAYMOND | ▲ Buy | Open Market | 508,306 | $579K | 10/10/2023 |
| WADE JEFFREY L | ▲ Buy | Open Market | 10,000 | $14K | 9/14/2023 |
| McDermott Wendy | ▲ Buy | Open Market | 6,000 | $11K | 8/4/2023 |
| COATS LONNEL | ▲ Buy | Open Market | 10,000 | $22K | 6/29/2023 |
| COATS LONNEL | ▲ Buy | Open Market | 10,000 | $22K | 6/26/2023 |
| McDermott Wendy | ▲ Buy | Open Market | 10,000 | $24K | 6/23/2023 |
| COATS LONNEL | ▲ Buy | Open Market | 10,000 | $25K | 6/23/2023 |
| COATS LONNEL | ▲ Buy | Open Market | 40,000 | $92K | 6/22/2023 |
| WADE JEFFREY L | ▲ Buy | Open Market | 10,000 | $23K | 6/20/2023 |
| WADE JEFFREY L | ▲ Buy | Open Market | 2,000 | $5K | 6/20/2023 |
| Artal International S.C.A. | ▲ Buy | Open Market | 27,775,050 | $72.2M | 6/5/2023 |
| Swain Judith L | ▲ Buy | Option Exercise | 9,302 | $0 | 5/21/2023 |
| SOBECKI CHRISTOPHER J | ▲ Buy | Option Exercise | 9,302 | $0 | 5/21/2023 |
| Palantoni Frank | ▲ Buy | Option Exercise | 9,302 | $0 | 5/21/2023 |
| NIES ALAN S | ▲ Buy | Option Exercise | 9,302 | $0 | 5/21/2023 |
| LEFKOWITZ ROBERT J MD | ▲ Buy | Option Exercise | 9,302 | $0 | 5/21/2023 |
| DEBBANE RAYMOND | ▲ Buy | Option Exercise | 9,302 | $0 | 5/21/2023 |
| Sam L. Barker | ▲ Buy | Option Exercise | 9,302 | $0 | 5/21/2023 |
| Philippe Amouyal | ▲ Buy | Option Exercise | 9,302 | $0 | 5/21/2023 |
| MAIN ALAN J | ▼ Sell | Tax Withholding | 20,946 | $45K | 2/28/2023 |
| Kassler-Taub Kenneth B. | ▲ Buy | Option Exercise | 18,243 | — | 2/28/2023 |
| Kassler-Taub Kenneth B. | ▲ Buy | Option Exercise | 7,086 | — | 2/28/2023 |
| Kassler-Taub Kenneth B. | ▲ Buy | Option Exercise | 27,557 | — | 2/28/2023 |
| Kassler-Taub Kenneth B. | ▼ Sell | Tax Withholding | 19,118 | $41K | 2/28/2023 |
| Granowitz Craig B | ▲ Buy | Option Exercise | 27,917 | — | 2/28/2023 |
| Granowitz Craig B | ▼ Sell | Tax Withholding | 12,732 | $28K | 2/28/2023 |
| Crum Brian T | ▲ Buy | Option Exercise | 21,030 | — | 2/28/2023 |
| Crum Brian T | ▲ Buy | Option Exercise | 8,750 | — | 2/28/2023 |
| Alexander Kristen | ▲ Buy | Option Exercise | 5,400 | — | 2/28/2023 |
| Alexander Kristen | ▲ Buy | Option Exercise | 2,700 | — | 2/28/2023 |
| Alexander Kristen | ▲ Buy | Option Exercise | 10,617 | — | 2/28/2023 |
| Alexander Kristen | ▼ Sell | Tax Withholding | 5,330 | $12K | 2/28/2023 |
| Seth Kiernan | ▲ Buy | Option Exercise | 14,833 | — | 2/28/2023 |
| Seth Kiernan | ▲ Buy | Option Exercise | 5,286 | — | 2/28/2023 |
| Seth Kiernan | ▲ Buy | Option Exercise | 22,963 | — | 2/28/2023 |
| Seth Kiernan | ▼ Sell | Tax Withholding | 11,813 | $26K | 2/28/2023 |
| McDermott Wendy | ▲ Buy | Option Exercise | 18,943 | — | 2/28/2023 |
| McDermott Wendy | ▼ Sell | Tax Withholding | 6,465 | $14K | 2/28/2023 |
| MAIN ALAN J | ▲ Buy | Option Exercise | 23,300 | — | 2/28/2023 |
| MAIN ALAN J | ▲ Buy | Option Exercise | 8,976 | — | 2/28/2023 |
| MAIN ALAN J | ▲ Buy | Option Exercise | 25,667 | — | 2/28/2023 |
| Crum Brian T | ▲ Buy | Option Exercise | 26,097 | — | 2/28/2023 |
| Crum Brian T | ▼ Sell | Tax Withholding | 20,537 | $45K | 2/28/2023 |
| WADE JEFFREY L | ▲ Buy | Option Exercise | 30,467 | — | 2/28/2023 |
| WADE JEFFREY L | ▲ Buy | Option Exercise | 11,176 | — | 2/28/2023 |
| WADE JEFFREY L | ▲ Buy | Option Exercise | 37,273 | — | 2/28/2023 |
| WADE JEFFREY L | ▼ Sell | Tax Withholding | 30,255 | $66K | 2/28/2023 |
| COATS LONNEL | ▲ Buy | Option Exercise | 84,630 | — | 2/28/2023 |
| COATS LONNEL | ▲ Buy | Option Exercise | 33,334 | — | 2/28/2023 |
| COATS LONNEL | ▲ Buy | Option Exercise | 91,363 | — | 2/28/2023 |
| COATS LONNEL | ▼ Sell | Tax Withholding | 50,971 | $111K | 2/28/2023 |
| Invus US Partners LLC | ▲ Buy | Open Market | 147,390 | $368K | 8/5/2022 |
| Artal International S.C.A. | ▲ Buy | Open Market | 2,426,070 | $6.1M | 8/5/2022 |
| Artal International S.C.A. | ▲ Buy | Open Market | 16,173,800 | $40.4M | 8/1/2022 |
| Invus US Partners LLC | ▲ Buy | Open Market | 982,600 | $2.5M | 8/1/2022 |
| DEBBANE RAYMOND | ▲ Buy | Open Market | 982,600 | $2.5M | 8/1/2022 |
| Philippe Amouyal | ▲ Buy | Option Exercise | 4,024 | $0 | 4/30/2022 |
| Swain Judith L | ▲ Buy | Option Exercise | 4,024 | $0 | 4/30/2022 |
| SOBECKI CHRISTOPHER J | ▲ Buy | Option Exercise | 4,024 | $0 | 4/30/2022 |
| Palantoni Frank | ▲ Buy | Option Exercise | 4,024 | $0 | 4/30/2022 |
| NIES ALAN S | ▲ Buy | Option Exercise | 4,024 | $0 | 4/30/2022 |
| LEFKOWITZ ROBERT J MD | ▲ Buy | Option Exercise | 4,024 | $0 | 4/30/2022 |
| DEBBANE RAYMOND | ▲ Buy | Option Exercise | 4,024 | $0 | 4/30/2022 |
| Sam L. Barker | ▲ Buy | Option Exercise | 4,024 | $0 | 4/30/2022 |
| Seth Kiernan | ▼ Sell | Tax Withholding | 8,261 | $24K | 2/28/2022 |
| MAIN ALAN J | ▲ Buy | Option Exercise | 22,373 | — | 2/28/2022 |
| MAIN ALAN J | ▲ Buy | Option Exercise | 23,300 | — | 2/28/2022 |
| MAIN ALAN J | ▲ Buy | Option Exercise | 8,977 | — | 2/28/2022 |
| Alexander Kristen | ▲ Buy | Option Exercise | 3,200 | — | 2/28/2022 |
| Alexander Kristen | ▲ Buy | Option Exercise | 5,400 | — | 2/28/2022 |
| Alexander Kristen | ▲ Buy | Option Exercise | 2,700 | — | 2/28/2022 |
| Alexander Kristen | ▼ Sell | Tax Withholding | 3,337 | $10K | 2/28/2022 |
| Seth Kiernan | ▲ Buy | Option Exercise | 10,007 | — | 2/28/2022 |
| Seth Kiernan | ▲ Buy | Option Exercise | 14,834 | — | 2/28/2022 |
| Seth Kiernan | ▲ Buy | Option Exercise | 5,287 | — | 2/28/2022 |
| MAIN ALAN J | ▼ Sell | Tax Withholding | 19,756 | $56K | 2/28/2022 |
| Kassler-Taub Kenneth B. | ▲ Buy | Option Exercise | 11,297 | — | 2/28/2022 |
| Kassler-Taub Kenneth B. | ▲ Buy | Option Exercise | 18,244 | — | 2/28/2022 |
| Kassler-Taub Kenneth B. | ▲ Buy | Option Exercise | 7,087 | — | 2/28/2022 |
| Kassler-Taub Kenneth B. | ▼ Sell | Tax Withholding | 13,241 | $38K | 2/28/2022 |
| Crum Brian T | ▲ Buy | Option Exercise | 11,100 | — | 2/28/2022 |
| Crum Brian T | ▲ Buy | Option Exercise | 21,030 | — | 2/28/2022 |
| Crum Brian T | ▲ Buy | Option Exercise | 8,750 | — | 2/28/2022 |
| Crum Brian T | ▼ Sell | Tax Withholding | 15,059 | $43K | 2/28/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
Lexicon Reports Consistent Heart Failure Drug Data in New Analysis
Lexicon Pharmaceuticals announced new analysis from the SOLOIST-WHF trial showing its drug sotagliflozin produced consistent results in patients with worsening heart failure across different baseline blood pressure levels. This post hoc analysis reinforces findings from the original trial studying hospitalized heart failure patients. The company also confirmed participation in three upcoming investor conferences, a routine corporate engagement practice. The data announcement represents the substantive news for this period.
Lexicon Reports Consistent Heart Failure Drug Data in New Analysis. Lexicon Pharmaceuticals announced new analysis from the SOLOIST-WHF trial showing its drug sotagliflozin produced consistent results in patients with worsening heart failure across different baseline blood pressure levels. This post hoc analysis reinforces findings from the original trial studying hospitalized heart failure patients. The company also confirmed participation in three upcoming investor conferences, a routine corporate engagement practice. The data announcement represents the substantive news for this period.